IFN Renassiance
15:40 - 16:00
Long Term Results of Peg-IFN Therapy in PV and ET
Dr. Srdan Verstovsek

Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX


 

Education

1994Ph.D., Natural Sciences, Faculty for Natural Sciences, University of Zagreb, Zagreb, Croatia
1992M.D., Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia

 

Professional Experience

2012~Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2012~Chief, Section for Myeloproliferative Neoplasms, Leukemia Department, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2012~Director, Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms, Leukemia Department, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2009~Medical Advisory Board Member, American Partnership for Eosinophilic Disorders
2005~Medical Advisory Board Member, The Mastocytosis Society
2005~Medical Advisory Board Member, The Chronic Myeloproliferative Disorders Education Foundation
2005~Executive Committee Member, International Working Group for Myelofibrosis Treatment and Research (IWG-MTR)
2003-2008Graduate Faculty, Graduate School of Biological Sciences, University of Texas, Houston, TX